Aralez Pharmaceuticals US – Court Approves Bidding Procedures, Bid Protections and Auction Timetable for VIMOVO and TOPROL Assets

October 11, 2018 – The Court hearing the Aralez Pharmaceuticals US case authorized the Debtors’ proposed (i) bidding and sale procedures related to the separate sales of (a) the Debtors’ VIMOVO royalties and Canadian operations to an acquisition subsidiary of Nuvo Pharmaceuticals in a transaction valued at $110 million and (b) the Debtors’ TOPROL assets…